Lexicon Pharmaceuticals, Inc.

NasdaqGS:LXRX Stock Report

Market Cap: US$654.3m

Lexicon Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Lexicon Pharmaceuticals has a total shareholder equity of $288.9M and total debt of $99.9M, which brings its debt-to-equity ratio to 34.6%. Its total assets and total liabilities are $417.2M and $128.4M respectively.

Key information

34.6%

Debt to equity ratio

US$99.87m

Debt

Interest coverage ration/a
CashUS$355.60m
EquityUS$288.87m
Total liabilitiesUS$128.35m
Total assetsUS$417.22m

Recent financial health updates

Recent updates

Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much

May 28

Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset

Mar 12

Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do

Jan 26

Here's Why Lexicon Pharmaceuticals (NASDAQ:LXRX) Can Manage Its Debt Despite Losing Money

Aug 08
Here's Why Lexicon Pharmaceuticals (NASDAQ:LXRX) Can Manage Its Debt Despite Losing Money

Is Lexicon Pharmaceuticals (NASDAQ:LXRX) A Risky Investment?

Apr 25
Is Lexicon Pharmaceuticals (NASDAQ:LXRX) A Risky Investment?

Does Lexicon Pharmaceuticals (NASDAQ:LXRX) Have A Healthy Balance Sheet?

Jan 04
Does Lexicon Pharmaceuticals (NASDAQ:LXRX) Have A Healthy Balance Sheet?

Lexicon Pharma: Key Regulatory Event In May 2023

Oct 01

Lexicon announces FDA review of heart failure therapy

Jul 27

Lexicon Pharmaceuticals: Encouraging Signs Of Efficacy In Pain, But Still Looking For A Clear Win

Jul 13

Lexicon Pharmaceuticals up 9% on mid-stage study for diabetic neuropathy drug

Jun 29

Financial Position Analysis

Short Term Liabilities: LXRX's short term assets ($364.6M) exceed its short term liabilities ($23.4M).

Long Term Liabilities: LXRX's short term assets ($364.6M) exceed its long term liabilities ($105.0M).


Debt to Equity History and Analysis

Debt Level: LXRX has more cash than its total debt.

Reducing Debt: LXRX had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LXRX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: LXRX has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 9.9% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.